Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Center Malta.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on July 1, 2025
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
GlobeNewswire
·
July 1, 2025
REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz …
Virtune announces the listing of Virtune Coinbase 50 Index ETP, its flagship product, on Euronext Paris
GlobeNewswire
·
July 1, 2025
Paris, July 1st, 2025 – Virtune AB, the Swedish regulated crypto asset manager, today announced the listing of Virtune Coinbase 50 Index ETP (VCOIN50) on Euronext Paris. The exchange-traded product (ETP) is now available to investors in France through …
Virtune annonce la cotation de son produit phare, Virtune Coinbase 50 Index ETP, sur Euronext Paris
GlobeNewswire
·
July 1, 2025
Paris, le 1er juillet 2025 – Virtune AB, gestionnaire d’actifs crypto réglementé en Suède, annonce aujourd’hui la cotation du Virtune Coinbase 50 Index ETP (VCOIN50) sur Euronext Paris. Ce produit négocié en bourse (ETP) est désormais accessible aux …
Virtune is listing Virtune Coinbase 50 Index ETP on Euronext Amsterdam and Paris
GlobeNewswire
·
July 1, 2025
Stockholm, July 1st, 2025 – Virtune, the Swedish regulated crypto asset manager, today announced the listing of Virtune Coinbase 50 Index ETP (VCOIN50) on Euronext Amsterdam and Paris. The exchange-traded product (ETP) is now available to investors in the …
Virtune noterar Virtune Coinbase 50 Index ETP på Euronext Amsterdam och Paris
GlobeNewswire
·
July 1, 2025
Stockholm, 1 juli 2025 – Virtune, den svenska reglerade kapitalförvaltaren av kryptotillgångar, meddelade idag noteringen av Virtune Coinbase 50 Index ETP (VCOIN50) på Euronext Amsterdam och Paris. Denna börshandlade produkt (ETP) är nu tillgänglig för …
Virtune announces the listing of Virtune Coinbase 50 Index ETP, its flagship product, on Euronext Amsterdam
GlobeNewswire
·
July 1, 2025
Amsterdam, July 1st, 2025 – Virtune AB, the Swedish regulated crypto asset manager, today announced the listing of Virtune Coinbase 50 Index ETP (VCOIN50) on Euronext Amsterdam. The exchange-traded product (ETP) is now available to investors in the …
Virtune kondigt notering aan van de Virtune Coinbase 50 Index ETP, haar vlaggenschipproduct, op Euronext Amsterdam
GlobeNewswire
·
July 1, 2025
Amsterdam, 1 juli 2025 – Virtune AB, de Zweedse gereguleerde vermogensbeheerder voor crypto-activa, kondigt vandaag de notering aan van de Virtune Coinbase 50 Index ETP (VCOIN50) op Euronext Amsterdam. Het beursgenoteerde product (ETP) is nu beschikbaar …
UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss
GlobeNewswire
·
July 1, 2025
Sheffield, July 01, 2025 (GLOBE NEWSWIRE) -- UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss Rincell-1 addresses a multi $Bn global market opportunity where no …
Verdict du jury populaire dans le procès TriZetto
GlobeNewswire
·
July 1, 2025
Communiqué de presse Verdict du jury populaire dans le procès TriZetto Paris – 1er juillet 2025. Le Groupe Atos prend acte du verdict rendu le 30 juin 2025 par un jury populaire de la Cour …
Lay jury verdict in the TriZetto trial
GlobeNewswire
·
July 1, 2025
Press Release Lay jury verdict in the TriZetto trial Paris – July 1st, 2025. Atos Group acknowledges that, on 30 June 2025, a lay jury in the United States District Court for the Southern …
Regents Gate Capital Selects big xyt for Enhanced Trading Analytics
GlobeNewswire
·
July 1, 2025
London, July 01, 2025 (GLOBE NEWSWIRE) -- big xyt, a leading independent provider of high-quality trade data and analytics, is pleased to announce its selection by Regents Gate Capital (RGC), a London-based alternative investment firm launched in mid-2024, …
ZetaDisplay and ENRA Technologies Partner to Drive Digital Signage Innovation in South Africa
GlobeNewswire
·
July 1, 2025
Leading European digital signage provider ZetaDisplay has announced an exciting new partnership with ENRA Technologies, a rapidly growing South African IT and AV solutions company, to accelerate the adoption of digital signage across South Africa and the …
Payscale Expands Global Footprint with Bucharest Technology Hub
GlobeNewswire
·
July 1, 2025
BOSTON, July 01, 2025 (GLOBE NEWSWIRE) -- Payscale Inc., the leading provider of compensation intelligence solutions, today announced the opening of its Bucharest Technology Hub to reinforce Payscale’s commitment to AI-driven innovation with access to …
Payscale își extinde acoperirea globală cu Centrul Tehnologic din București
GlobeNewswire
·
July 1, 2025
BOSTON, July 01, 2025 (GLOBE NEWSWIRE) -- Payscale Inc., cel mai mare furnizor de soluții de informații despre compensare, a anunțat astăzi deschiderea Centrului său Tehnologic din București pentru a consolida angajamentul Payscale față de inovația bazată …
ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility
GlobeNewswire
·
July 1, 2025
RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosterone No FDA-approved oral therapies currently exist for this underserved population LAUSANNE, Switzerland and …
Zscaler Announces Pricing of $1.5 Billion Offering of 0.00% Convertible Senior Notes Due 2028
GlobeNewswire
·
July 1, 2025
SAN JOSE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (Nasdaq: ZS) today announced the pricing of $1.5 billion aggregate principal amount of 0.00% convertible senior notes due 2028 (the “notes”) in a private offering to persons reasonably …
NetAlly Launches AllyWare v2.8 Software Update, Delivering Enhanced Performance and Additional Wi-Fi 7 Visibility to Network Testers
GlobeNewswire
·
July 1, 2025
COLORADO SPRINGS, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- NetAlly, a leading innovator in handheld network testing solutions, today announced the release of AllyWare™ v2.8, the latest software update across its award-winning line of network testers, …
Rakovina Therapeutics Announces Intention to Amend Debentures and Warrants
GlobeNewswire
·
July 1, 2025
VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”) announces that it will apply to the TSX Venture Exchange (the “Exchange”) to amend the terms of certain outstanding warrants and …
Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock
GlobeNewswire
·
July 1, 2025
WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the pricing of …
Acceleware Announces Non-Brokered Private Placement of Units and Shares for Debt Transactions
GlobeNewswire
·
July 1, 2025
CALGARY, Alberta, June 30, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine …